A 28-Year-Old Woman With Left-Sided Weakness and Atypical MRI Lesions: From the National Multiple Sclerosis Society Case Conference Proceedings.

MedStar author(s):
Citation: Neurology neuroimmunology & neuroinflammation. 10(6), 2023 11.PMID: 37673687Department: MedStar Georgetown University Hospital/MedStar Washington Hospital Center | Multiple Sclerosis FellowshipForm of publication: Journal ArticleMedline article type(s): Case Reports | Journal Article | Research Support, Non-U.S. Gov'tSubject headings: *Multiple Sclerosis | Adult | Biopsy | Female | Humans | Immunosuppression Therapy | Magnetic Resonance Imaging | Multiple Sclerosis/dg [Diagnostic Imaging] | Year: 2023ISSN:
  • 2332-7812
Name of journal: Neurology(R) neuroimmunology & neuroinflammationAbstract: A 28-year-old woman presented with subacute relapsing left-sided weakness. MRI demonstrated both enhancing C3-C6 and nonenhancing T2-T4 lesions. Initial provisional diagnosis was inflammatory/autoimmune. Her left-sided weakness progressed despite immunosuppressive therapies. We reassessed our original suspected diagnosis because of an atypical clinicoradiologic course, leading to biopsy and a definitive diagnosis. Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.All authors: Safadi AL, Osborne B, Chitnis T, Graves JS, Newsome SD, Zamvil SS, Solomon IH, Shin RKFiscal year: FY2024Digital Object Identifier: ORCID: Date added to catalog: 2023-11-22
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 37673687 Available 37673687

A 28-year-old woman presented with subacute relapsing left-sided weakness. MRI demonstrated both enhancing C3-C6 and nonenhancing T2-T4 lesions. Initial provisional diagnosis was inflammatory/autoimmune. Her left-sided weakness progressed despite immunosuppressive therapies. We reassessed our original suspected diagnosis because of an atypical clinicoradiologic course, leading to biopsy and a definitive diagnosis. Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

English

Powered by Koha